- Zhu R, .et al. Cancer-selective bioreductive chemotherapy mediated by dual hypoxia-responsive nanomedicine upon photodynamic therapy-induced hypoxia aggravation, Biomacromolecules, 2019, May 24 PMID: 31125209
Biological Activity
Tirapazamine is a bioreductive, anti-neoplastic, anti-cancer agent that is selectively toxic to cells under hypoxic conditions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 56.13 mL | 280.66 mL | 561.32 mL |
0.5 mM | 11.23 mL | 56.13 mL | 112.26 mL |
1 mM | 5.61 mL | 28.07 mL | 56.13 mL |
5 mM | 1.12 mL | 5.61 mL | 11.23 mL |
*The above data is based on the productmolecular weight 178.15. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A12754 |
---|---|
M. Wt | 178.15 |
Formula | C7H6N4O2 |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 27314-97-2 |
SMILES | C1=CC=C2C(=C1)N(C(=N)N=[N+]2[O-])O |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy Tirapazamine | Tirapazamine Supplier | purchase | cost | manufacturer | order | distributor | buy 27314-97-2| 27314-97-2 Supplier | purchase 27314-97-2 | 27314-97-2 cost | 27314-97-2 manufacturer | order 27314-97-2 | 27314-97-2 distributor